fig1

MASLD: an emerging factor in the pathophysiology and clinical management of ICC

Figure 1. Potential pathogenesis of MASLD-related ICC. MASH: Metabolic dysfunction-associated steatohepatitis; MetS: metabolic syndrome; HC: hepatic cells; YAP 1: yes-associated protein 1; SOX 9: SRY-box transcription factor 9; OPN: osteopontin; TnC: tenascin-C; POSTN: periostin; ICC: intrahepatic cholangiocarcinoma.

Hepatoma Research
ISSN 2454-2520 (Online) 2394-5079 (Print)

Portico

All published articles are preserved here permanently:

https://www.portico.org/publishers/oae/

Portico

All published articles are preserved here permanently:

https://www.portico.org/publishers/oae/